Literature DB >> 18077517

CELLDOSE: a Monte Carlo code to assess electron dose distribution--S values for 131I in spheres of various sizes.

Christophe Champion1, Paolo Zanotti-Fregonara, Elif Hindié.   

Abstract

UNLABELLED: Monte Carlo simulation can be particularly suitable for modeling the microscopic distribution of energy received by normal tissues or cancer cells and for evaluating the relative merits of different radiopharmaceuticals. We used a new code, CELLDOSE, to assess electron dose for isolated spheres with radii varying from 2,500 mum down to 0.05 mum, in which (131)I is homogeneously distributed.
METHODS: All electron emissions of (131)I were considered, including the whole beta(- 131)I spectrum, 108 internal conversion electrons, and 21 Auger electrons. The Monte Carlo track-structure code used follows all electrons down to an energy threshold E(cutoff) = 7.4 eV.
RESULTS: Calculated S values were in good agreement with published analytic methods, lying in between reported results for all experimental points. Our S values were also close to other published data using a Monte Carlo code. Contrary to the latter published results, our results show that dose distribution inside spheres is not homogeneous, with the dose at the outmost layer being approximately half that at the center. The fraction of electron energy retained within the spheres decreased with decreasing radius (r): 87.1% for r = 2,500 mum, 8.73% for r = 50 mum, and 1.18% for r = 5 mum. Thus, a radioiodine concentration that delivers a dose of 100 Gy to a micrometastasis of 2,500 mum radius would deliver 10 Gy in a cluster of 50 mum and only 1.4 Gy in an isolated cell. The specific contribution from Auger electrons varied from 0.25% for the largest sphere up to 76.8% for the smallest sphere.
CONCLUSION: The dose to a tumor cell will depend on its position in a metastasis. For the treatment of very small metastases, (131)I may not be the isotope of choice. When trying to kill isolated cells or a small cluster of cells with (131)I, it is important to get the iodine as close as possible to the nucleus to get the enhancement factor from Auger electrons. The Monte Carlo code CELLDOSE can be used to assess the electron map deposit for any isotope.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18077517     DOI: 10.2967/jnumed.107.045179

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  10 in total

1.  Reply to: Determinants of (131)I radiation dose to thyroid follicular cells.

Authors:  E Hindié; C Champion; P Zanotti-Fregonara; D Rubello; J L Moretti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-06       Impact factor: 9.236

2.  Calculation of electron dose to target cells in a complex environment by Monte Carlo code "CELLDOSE".

Authors:  Elif Hindié; Christophe Champion; Paolo Zanotti-Fregonara; Domenico Rubello; Nicole Colas-Linhart; Laura Ravasi; Jean-Luc Moretti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-09       Impact factor: 9.236

3.  Nanodosimetry of Auger electrons: A case study from the decay of 125I and 0-18-eV electron stopping cross sections of cytosine.

Authors:  M Michaud; M Bazin; L Sanche
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2013-03-04

4.  Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.

Authors:  Dongyoul Lee; Mengshi Li; Bryan Bednarz; Michael K Schultz
Journal:  Radiat Res       Date:  2018-06-26       Impact factor: 2.841

5.  Modeling therapeutic response to radioiodine in metastatic thyroid cancer: a proof-of-concept study for individualized medicine.

Authors:  Dominique Barbolosi; Ilyssa Summer; Christophe Meille; Raphaël Serre; Antony Kelly; Slimane Zerdoud; Claire Bournaud; Claire Schvartz; Michel Toubeau; Marie-Elisabeth Toubert; Isabelle Keller; David Taïeb
Journal:  Oncotarget       Date:  2017-06-13

6.  The combined therapeutic effects of 131iodine-labeled multifunctional copper sulfide-loaded microspheres in treating breast cancer.

Authors:  Qiufang Liu; Yuyi Qian; Panli Li; Sihang Zhang; Zerong Wang; Jianjun Liu; Xiaoguang Sun; Michael Fulham; Dagan Feng; Zhigang Chen; Shaoli Song; Wei Lu; Gang Huang
Journal:  Acta Pharm Sin B       Date:  2018-04-07       Impact factor: 11.413

7.  Radiation doses from 161Tb and 177Lu in single tumour cells and micrometastases.

Authors:  Mario E Alcocer-Ávila; Aymeric Ferreira; Michele A Quinto; Clément Morgat; Elif Hindié; Christophe Champion
Journal:  EJNMMI Phys       Date:  2020-05-19

8.  Dosimetric analysis of (123)I, (125)I and (131)I in thyroid follicle models.

Authors:  Anders Josefsson; Eva Forssell-Aronsson
Journal:  EJNMMI Res       Date:  2014-06-11       Impact factor: 3.138

9.  Comparison between Three Promising ß-emitting Radionuclides, (67)Cu, (47)Sc and (161)Tb, with Emphasis on Doses Delivered to Minimal Residual Disease.

Authors:  Christophe Champion; Michele A Quinto; Clément Morgat; Paolo Zanotti-Fregonara; Elif Hindié
Journal:  Theranostics       Date:  2016-06-18       Impact factor: 11.556

10.  131I-Labeled Copper Sulfide-Loaded Microspheres to Treat Hepatic Tumors via Hepatic Artery Embolization.

Authors:  Qiufang Liu; Yuyi Qian; Panli Li; Sihang Zhang; Jianjun Liu; Xiaoguang Sun; Michael Fulham; Dagan Feng; Gang Huang; Wei Lu; Shaoli Song
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.